Product image of Melvedok (Moxifloxacin) supplied by GNH India

Melvedok

Active Ingredient:
Moxifloxacin
Origin:
EU

Melvedok (Moxifloxacin)

Moxifloxacin, the active ingredient in Melvedok, is a fluoroquinolone antibiotic presented as an oral formulation for oral use. It treats a range of bacterial infections, including respiratory and skin infections, in adult patients as prescribed by a healthcare professional and is commonly employed in community‑acquired infections.

GNH India supplies Melvedok as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance. Our distribution network ensures timely delivery across multiple regions.

Manufacturer / TM Owner

Alkaloid-Int D.O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Moxifloxacin is indicated for several bacterial infections affecting the respiratory tract and skin.
  • Community‑acquired pneumonia: effective treatment of bacterial lung infection in adults.
  • Acute bacterial sinusitis: eradicates the causative pathogens in sinus inflammation.
  • Acute bacterial exacerbation of chronic bronchitis: reduces bacterial load during flare‑ups.
  • Skin and soft tissue infections: combats Gram‑positive and Gram‑negative organisms in cutaneous lesions.

How It Works

  • Moxifloxacin exerts its antibacterial activity by binding to bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA supercoiling and replication. Inhibition of these targets prevents DNA synthesis and transcription, leading to bacterial cell death. The drug displays concentration‑dependent killing and a post‑antibiotic effect against a broad spectrum of Gram‑positive and Gram‑negative organisms and is active against atypical pathogens such as Mycoplasma pneumoniae.

Side Effects

Moxifloxacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Nausea: mild gastrointestinal upset.
  • Diarrhea: loose stools, usually self‑limiting.
  • Headache: transient cranial discomfort.
  • Dizziness: occasional vertigo.
  • Rash: mild skin erythema.
  • Photosensitivity: increased sun sensitivity.

Serious or Rare Side Effects

  • Tendon rupture: especially Achilles tendon, may occur without warning.
  • QT interval prolongation: risk of cardiac arrhythmias.
  • Severe allergic reactions: anaphylaxis, angioedema.
  • Clostridioides difficile‑associated diarrhea: potentially life‑threatening colitis.
  • Hepatic injury: elevated liver enzymes or hepatitis.
  • Peripheral neuropathy: numbness or tingling in extremities.

Precautions & Warnings

  • When prescribing Moxifloxacin, clinicians should consider several safety precautions to minimize risk.
  • Assess renal and hepatic function: adjust use in patients with impairment.
  • Avoid in patients with known QT interval prolongation: may increase arrhythmia risk.
  • Use with caution in elderly: higher incidence of tendon disorders.
  • Review allergy history: contraindicated in patients with fluoroquinolone hypersensitivity.
  • Monitor for tendon pain or swelling: discontinue if symptoms appear.
  • Store at ambient temperature below 25°C: keep in original packaging, protect from moisture.

Avoid Interactions

Moxifloxacin can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Concurrent use with other fluoroquinolones: additive toxicity.
  • Co‑administration with drugs that prolong QT interval (e.g., quinidine, sotalol, azithromycin): increased risk of cardiac arrhythmias.
  • Combination with antacids or supplements containing aluminum, magnesium, calcium, or iron: reduces absorption of moxifloxacin.

Moderate Interactions (Monitor Closely)

  • Warfarin: may enhance anticoagulant effect, monitor INR.
  • Theophylline: may increase plasma levels, watch for toxicity.
  • Cyclosporine: may raise cyclosporine concentrations, adjust dose as needed.

Frequently Asked Questions

Melvedok contains moxifloxacin and is used to treat several bacterial infections, including community‑acquired pneumonia, acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and skin and soft‑tissue infections. It is prescribed for adult patients when a fluoroquinolone antibiotic is appropriate.

Moxifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. By blocking these targets, the drug prevents bacterial DNA synthesis, leading to rapid bacterial cell death and a post‑antibiotic effect against a broad range of Gram‑positive, Gram‑negative, and atypical organisms.

The dosage of Melvedok is determined by the prescribing clinician based on the specific infection, patient characteristics, and local guidelines. Healthcare professionals select the appropriate strength, frequency, and duration, and patients should follow the prescriber’s instructions exactly.

Safety data for moxifloxacin during pregnancy and lactation are limited. The drug should only be used when the potential benefit justifies any potential risk to the fetus or infant. Clinicians must evaluate the risk‑benefit ratio and discuss it with the patient.

To order Melvedok, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials. The team then replies with pricing, availability, shipping details and any necessary import documentation.

Both moxifloxacin and levofloxacin belong to the fluoroquinolone class and share a similar mechanism of action. Moxifloxacin generally offers a broader spectrum against anaerobes and atypical pathogens and has a longer half‑life, allowing once‑daily dosing for many indications, whereas levofloxacin may require twice‑daily dosing for some infections.

Melvedok should be stored at ambient temperature below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keep the product out of reach of children and do not use it after the expiration date.

Melvedok is administered orally. The tablet should be swallowed whole with a full glass of water and may be taken with or without food, unless the prescriber advises otherwise. Patients should avoid taking antacids or mineral supplements within two hours of the dose to ensure optimal absorption.

The most serious risks include tendon rupture (especially in the Achilles tendon), QT interval prolongation leading to potentially life‑threatening arrhythmias, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and hepatic injury. Patients should be instructed to seek immediate medical attention if they experience tendon pain, palpitations, rash, or persistent diarrhea.

Melvedok is contraindicated in patients with a known hypersensitivity to moxifloxacin, other fluoroquinolones, or any component of the formulation. It should also be avoided in individuals with a history of QT prolongation, ventricular arrhythmias, or those taking other QT‑prolonging drugs without careful monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Moxifloxacin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT